Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

3.94USD
5:20pm BST
Change (% chg)

$-0.11 (-2.72%)
Prev Close
$4.05
Open
$4.03
Day's High
$4.06
Day's Low
$3.84
Volume
129,447
Avg. Vol
403,556
52-wk High
$10.73
52-wk Low
$3.84

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Adrian Adams

68 2018 Independent Chairman of the Board

John Butler

54 2013 President, Chief Executive Officer, Director

Jason Amello

50 2013 Chief Financial Officer, Senior Vice President, Treasurer

Nicole Hadas

46 2013 Senior Vice President, Chief Legal Officer and Secretary

Steven Burke

57 2019 Senior Vice President, Chief Medical Officer